MSP Recovery PE Ratio 2020-2024 | MSPR

Current and historical p/e ratio for MSP Recovery (MSPR) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MSP Recovery PE ratio as of January 14, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

MSP Recovery PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-01-13 2.15 0.00
2024-09-30 0.15 $-144.25 0.00
2024-03-31 0.69 $-156.50 0.00
2023-12-31 2.27 $-125.00 0.00
2023-09-30 0.21 $-82.75 0.00
2023-06-30 0.33 $-81.00 0.00
2023-03-31 0.85 $-43.50 0.00
2022-12-31 1.60 $-99.75 0.00
2024-06-30 0.46 $-99.75 0.00
2022-09-30 1.20 $-62.50 0.00
2022-06-30 2.14 $-56.25 0.00
2022-03-31 10.26 0 0.00
2021-12-31 9.96 0 0.00
2021-09-30 9.91 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.014B $0.008B
MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $6.068B 189.23
Tempus AI (TEM) United States $5.907B 0.00
Hims & Hers Health (HIMS) United States $5.552B 141.17
IRhythm Technologies (IRTC) United States $3.058B 0.00
Enovis (ENOV) United States $2.502B 16.96
Privia Health (PRVA) United States $2.461B 205.10
Azenta (AZTA) United States $2.362B 126.10
Omnicell (OMCL) United States $1.958B 64.06
10x Genomics (TXG) United States $1.886B 0.00
Clover Health Investments (CLOV) United States $1.824B 0.00
Phreesia (PHR) United States $1.551B 0.00
Schrodinger (SDGR) United States $1.405B 0.00
Butterfly Network (BFLY) United States $0.765B 0.00
Standard BioTools (LAB) United States $0.607B 0.00
Fulgent Genetics (FLGT) United States $0.560B 0.00
Talkspace (TALK) United States $0.493B 0.00
Definitive Healthcare (DH) United States $0.488B 84.40
Health Catalyst (HCAT) United States $0.419B 0.00
TruBridge (TBRG) United States $0.319B 93.04
Pulmonx (LUNG) United States $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
American Well (AMWL) United States $0.111B 0.00
EUDA Health Holdings (EUDA) Singapore $0.109B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
CareCloud (CCLD) United States $0.049B 0.00
Outset Medical (OM) United States $0.048B 0.00
Zepp Health (ZEPP) China $0.048B 0.00
Zhongchao (ZCMD) China $0.045B 0.00
111 (YI) China $0.042B 0.00
Movano (MOVE) United States $0.039B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00
SHL Telemedicine (SHLT) Israel $0.000B 0.00